Welcome, this website is intended for international healthcare professionals with an interest in the treatment of Advanced Prostate Cancer. By clicking the link below you are declaring and confirming that you are a healthcare professional

You are here

INTERVIEW WITH PROF. NOEL CLARKE ON METASTATIC CRPC

EMUC 2012 - Professor Noel Clarke

In a Q&A interview following a plenary session on metastatic castration-resistant prostate cancer (CRPC) held during the 4th EMUC in Barcelona, Noel Clarke (Manchester, UK) discussed his opinions regarding the hormonal and therapeutic options for metastatic CRPC. Besides the side effects and other challenges, he mentioned the efficacy, prospects and impact of hormonal treatment in view of current trials.

The content of the videos, articles and all statements expressed therein do not necessarily reflect the opinions or views of the Editors, Authors or Reviewers of European Urology.